Published by Global Banking and Finance Review
Posted on February 6, 2025
1 min readLast updated: January 26, 2026
AstraZeneca CEO Pascal Soriot states the company has no access to detained executive Leon Wang in China, following an investigation by authorities.
LONDON (Reuters) - AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's former senior executive Leon Wang and has provided information as needed, its chief executive said on Thursday.
The company has no further information to share about Wang and is not permitted by Chinese authorities to speak to him, Pascal Soriot said at a press conference after the company released fourth-quarter results.
AstraZeneca placed Wang on extended leave in December from his position as international executive vice president and China president, following his detention in October.
(Reporting by Maggie Fick and Pushkala Aripaka)
The main topic is the detention of AstraZeneca's former executive Leon Wang in China and the company's response.
The article does not specify the reasons for Leon Wang's detention, only that Chinese authorities are investigating.
CEO Pascal Soriot stated that the company has no access to Leon Wang and has provided information to Chinese authorities as needed.
Explore more articles in the Headlines category
